Drug Side Effects
Search
ENDOMETRIAL SARCOMA
ENDOMETRIAL SARCOMA
was reported 29 times
ENDOMETRIAL SARCOMA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
7
0.0003
1
Protease Inhibitor [EPC]
5
0.0001
2
Cytochrome P450 3A Inhibitor [EPC]
5
0.0001
3
CD52-directed Cytolytic Antibody [EPC]
1
0.0001
4
Progesterone [EPC]
1
0.0000
5
Provitamin D2 Compound [EPC]
1
0.0000
6
Calcium [EPC]
4
0.0000
7
Estrogen Receptor Antagonist [EPC]
1
0.0000
8
Pyrimidine Synthesis Inhibitor [EPC]
1
0.0000
9
gamma-Aminobutyric Acid-ergic Agonist [EPC]
1
0.0000
10
Aromatase Inhibitor [EPC]
1
0.0000
11
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
12
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
13
Leukocyte Growth Factor [EPC]
1
0.0000
14
Dihydropyridine Calcium Channel Blocker [EPC]
2
0.0000
15
Thalidomide Analog [EPC]
3
0.0000
16
Interferon beta [EPC]
1
0.0000
17
Alkylating Drug [EPC]
1
0.0000
18
Nucleoside Metabolic Inhibitor [EPC]
1
0.0000
19
beta-Adrenergic Blocker [EPC]
1
0.0000
20
Tumor Necrosis Factor Blocker [EPC]
3
0.0000
21
Corticosteroid [EPC]
3
0.0000
22
Kinase Inhibitor [EPC]
1
0.0000
23
Platelet Aggregation Inhibitor [EPC]
1
0.0000
24
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000